Inherited Mutations in Chinese Men With Prostate Cancer

医学 前列腺癌 种系突变 优势比 肿瘤科 危险系数 内科学 生殖系 突变 癌症 遗传学 置信区间 基因 生物
作者
Yao Zhu,Wei Yu,Hao Zeng,Yonghong Li,Chi‐Fai Ng,Fangjian Zhou,Caiyun He,Guangxi Sun,Yuchao Ni,Peter Ka‐Fung Chiu,Jeremy Yuen‐Chun Teoh,Beihe Wang,Jian Gang Pan,Fangning Wan,Bo Dai,Xiaojian Qin,Guowen Lin,Hualei Gan,Junlong Wu,Dingwei Ye
出处
期刊:Journal of The National Comprehensive Cancer Network [National Comprehensive Cancer]
卷期号:20 (1): 54-62 被引量:32
标识
DOI:10.6004/jnccn.2021.7010
摘要

BACKGROUND: Although China accounts for 7.8% of worldwide new prostate cancer (PCa) cases and 14.5% of new deaths according to GLOBOCAN 2020, the risk of PCa associated with germline mutations is poorly defined, hampered in part by lack of nationwide evidence. Here, we sequenced 19 PCa predisposition genes in 1,836 Chinese patients with PCa and estimated disease risk associated with inherited mutations. PATIENTS AND METHODS: Patients were recruited from 4 tertiary cancer centers (n=1,160) and a commercial laboratory (n=676). Germline DNA was sequenced using a multigene panel, and pathogenic/likely pathogenic (P/LP) mutation frequencies in patients with PCa were compared with populations from the gnomAD (Genome Aggregation Database) and ChinaMAP (China Metabolic Analytics Project) databases. Clinical characteristics and progression-free survival were assessed by mutation status. RESULTS: Of 1,160 patients from hospitals, 89.7% had Gleason scores ≥8, and 65.6% had metastases. P/LP mutations were identified in 8.49% of Chinese patients with PCa. Association with PCa risk was significant for mutations in ATM (odds ratio [OR], 5.9; 95% CI, 3.1-11.1), BRCA2 (OR, 15.3; 95% CI, 10.0-23.2), MSH2 (OR, 15.8; 95% CI, 4.2-59.6), and PALB2 (OR, 5.9; 95% CI, 2.7-13.2). Compared with those without mutations, patients with mutations in ATM, BRCA2, MSH2, or PALB2 showed a poor outcome with treatment using androgen deprivation therapy and abiraterone (hazard ratio, 2.19 [95% CI, 1.34-3.58] and 2.47 [95% CI, 1.23-4.96], respectively) but similar benefit from docetaxel. CONCLUSIONS: The present multicenter study confirmed that a significant proportion of Chinese patients with PCa had inherited mutations and identified predisposition genes in this underreported ethnicity. These data provide empirical evidence for precision prevention and prognostic estimation in Chinese patients with PCa.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
NexusExplorer的应助被Zyumi采纳,获得10
1秒前
哈哈完成签到,获得积分10
2秒前
明明完成签到,获得积分10
2秒前
小秃子完成签到,获得积分10
2秒前
2秒前
MOMO完成签到,获得积分20
3秒前
yz123发布了新的文献求助10
4秒前
Stella完成签到 ,获得积分10
4秒前
时嗷完成签到,获得积分10
4秒前
吴晨曦发布了新的文献求助10
4秒前
5秒前
5秒前
6秒前
哈哈发布了新的文献求助10
7秒前
Zyumi完成签到,获得积分10
7秒前
顾矜的应助被科研通管家采纳,获得10
7秒前
追光完成签到,获得积分10
7秒前
bkagyin的应助被科研通管家采纳,获得10
7秒前
FashionBoy的应助被科研通管家采纳,获得10
8秒前
8秒前
8秒前
君子之昔发布了新的文献求助10
8秒前
8秒前
Skye的应助被科研通管家采纳,获得10
8秒前
8秒前
8秒前
充电宝的应助被科研通管家采纳,获得10
8秒前
Akim的应助被科研通管家采纳,获得10
8秒前
所所的应助被科研通管家采纳,获得10
8秒前
9秒前
风吹麦浪的应助被科研通管家采纳,获得10
9秒前
斯文败类的应助被科研通管家采纳,获得10
9秒前
酷波er的应助被科研通管家采纳,获得10
9秒前
英姑的应助被风吹麦浪采纳,获得30
9秒前
秋风的应助被科研通管家采纳,获得10
9秒前
今后的应助被科研通管家采纳,获得10
9秒前
秋风的应助被科研通管家采纳,获得10
9秒前
9秒前
DrMA的应助被科研通管家采纳,获得50
9秒前
华仔的应助被科研通管家采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175142
求助须知:如何正确求助?哪些是违规求助? 9566928
关于积分的说明 21789123
捐赠科研通 7769522
什么是DOI,文献DOI怎么找? 3431822
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477222